Health analytics

Market access and evidence generation strategy

Our strategic services help clients to navigate uncertainties and maximise value throughout development and commercialisation of products.

We enable market access through provision of insights that inform development of optimal payer evidence and access strategies, while also providing solutions that help execute on the strategy. Our tailored approach aims to provide market access insights and solutions across all stages of the product lifecycle.

We link global value strategies to local health system needs and priorities

At LCP Health Analytics, we recognise that securing access and reimbursement for novel therapies demands a strategic approach tailored to each product and market. Our dedicated market access team goes beyond generic consulting models to provide an integrated, bespoke service reflecting your specific needs for value demonstration, pricing strategy, and payer engagement.

We foster early payer involvement through our global payer network for value demonstration, access and pricing, enabling successful launches. We quantify the full range of tangible and intangible value elements of your therapy to payers and health systems using real-world evidence. We also have extensive experience in co-creating innovative outcome-based agreements responsive to healthcare priorities.

With real-world analytics integral to our market access approach, we stand distinct from typical market access consultancies through linking global value strategies to local health system needs and priorities. Our goal is to help you achieve broad, rapid and sustainable patient access.

We support our clients across the following areas:

Evidence generation strategy

Evidence gap analysis
Data landscaping
Assessment of payer acceptability
Payer rationalised trial design advisory
Development of cross-functional, RWE strategy across the lifecycle

Global market access consulting

Pricing, reimbursement and competitor landscape assessment
Payer research/advisory boards
Market access strategy/roadmap
Portfolio planning
Business development/licensing evaluation i.e., opportunity assessment/asset due diligence